Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;21(4):719-728.
doi: 10.1007/s42000-022-00408-4. Epub 2022 Oct 25.

Serum growth differentiation factor-15 levels are associated with the severity of diabetic foot ulcer

Affiliations

Serum growth differentiation factor-15 levels are associated with the severity of diabetic foot ulcer

Suleyman Nahit Sendur et al. Hormones (Athens). 2022 Dec.

Abstract

Aims: To assess serum growth differentiation factor-15 (GDF-15) levels in patients with diabetic foot ulcer and to reveal whether any association exists between GDF-15 and the severity of diabetic foot ulcer.

Design: A cross-sectional study including three age- and sex-matched cohorts comprising 17 patients (7 F, mean age: 52 ± 7 years) with diabetic foot ulcer (DMf), 17 patients with type 2 diabetes (6 F, mean age: 51 ± 6 years) with no foot complication (DM), and 20 healthy controls (8 F, mean age: 50 ± 8 years) (C) was conducted.

Results: DMf had higher GDF-15 levels, followed by DM and C (GDF-15, median ± IQR (pg/mL), DMf: 1039 (884-1566), DM: 649 (375-1148), and C: 296 (212-534), p < 0.001). The severity of diabetic foot disease was positively associated with serum GDF-15 (GDF-15, median ± IQR (pg/mL), Wagner grade 1: 893 (698-1039), Wagner grade 3: 1705 (1348-2197), and Wagner grade 4: 3075 (1974-4176), p for trend = 0.006). In multivariate regression model, only Wagner grade (β = 0.55, 95% CI (87-753), p = 0.02) was found to be an independent factor affecting serum GDF-15 concentration.

Conclusions: Serum GDF-15 levels are high in patients with diabetic foot ulcer. The level is higher in more advanced lesions. GDF-15 measurement can have clinical utility in the management of diabetic foot ulcers.

Keywords: Complication; Diabetic foot; GDF-15; Type 2 diabetes mellitus; Wagner grade.

PubMed Disclaimer

References

    1. IDF Diabetes Atlas Tenth Edition, Belgium. International Diabetes Federation (2019) https://diabetesatlas.org/
    1. Armstrong DG, Boulton AJM, Bus SA (2017) Diabetic foot ulcers and their recurrence. N Engl J Med 376(24):2367–2375. https://doi.org/10.1056/NEJMra1615439 - DOI - PubMed
    1. Wu SC, Driver VR, Wrobel JS, Armstrong DG (2007) Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag 3(1):65–76 - PubMed - PMC
    1. Wischhusen J, Melero I, Fridman WH (2020) Growth/differentiation factor -15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol 11:951. https://doi.org/10.3389/fimmu.2020.00951 - DOI - PubMed - PMC
    1. Wollert KC, Kempf T, Wallentin L (2017) Growth differentiation factor 15 as a biomarker in cardiovascular disease. Clin Chem 63(1):140–151. https://doi.org/10.1373/clinchem.2016.255174 - DOI - PubMed

Substances

LinkOut - more resources